These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34870700)

  • 21. NCL diseases - clinical perspectives.
    Schulz A; Kohlschütter A; Mink J; Simonati A; Williams R
    Biochim Biophys Acta; 2013 Nov; 1832(11):1801-6. PubMed ID: 23602993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased zinc and manganese in parallel with neurodegeneration, synaptic protein changes and activation of Akt/GSK3 signaling in ovine CLN6 neuronal ceroid lipofuscinosis.
    Kanninen KM; Grubman A; Meyerowitz J; Duncan C; Tan JL; Parker SJ; Crouch PJ; Paterson BM; Hickey JL; Donnelly PS; Volitakis I; Tammen I; Palmer DN; White AR
    PLoS One; 2013; 8(3):e58644. PubMed ID: 23516525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).
    Hawkins-Salsbury JA; Cooper JD; Sands MS
    Biochim Biophys Acta; 2013 Nov; 1832(11):1906-9. PubMed ID: 23747979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.
    Kollmann K; Uusi-Rauva K; Scifo E; Tyynelä J; Jalanko A; Braulke T
    Biochim Biophys Acta; 2013 Nov; 1832(11):1866-81. PubMed ID: 23402926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental Therapeutic Approaches for the Treatment of Retinal Pathology in Neuronal Ceroid Lipofuscinoses.
    Bartsch U; Storch S
    Front Neurol; 2022; 13():866983. PubMed ID: 35509995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling of Neuronal Ceroid Lipofuscinosis Type 2 in
    Smith PK; Sen MG; Fisher PR; Annesley SJ
    Cells; 2019 May; 8(5):. PubMed ID: 31100984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses.
    Mukherjee AB; Appu AP; Sadhukhan T; Casey S; Mondal A; Zhang Z; Bagh MB
    Mol Neurodegener; 2019 Jan; 14(1):4. PubMed ID: 30651094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.
    Villani NA; Bullock G; Michaels JR; Yamato O; O'Brien DP; Mhlanga-Mutangadura T; Johnson GS; Katz ML
    Mol Genet Metab; 2019 May; 127(1):107-115. PubMed ID: 31101435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.
    Katz ML; Rustad E; Robinson GO; Whiting REH; Student JT; Coates JR; Narfstrom K
    Neurobiol Dis; 2017 Dec; 108():277-287. PubMed ID: 28860089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathomechanisms in the neuronal ceroid lipofuscinoses.
    Nelvagal HR; Lange J; Takahashi K; Tarczyluk-Wells MA; Cooper JD
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165570. PubMed ID: 31678162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy.
    Hughes SM; Hope KM; Xu JB; Mitchell NL; Palmer DN
    Neurobiol Dis; 2014 Feb; 62():543-50. PubMed ID: 24269732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms regulating the intracellular trafficking and release of CLN5 and CTSD.
    Huber RJ; Kim WD; Wilson-Smillie MLDM
    Traffic; 2024 Jan; 25(1):e12925. PubMed ID: 38272448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An altered transcriptome underlies
    Kim WD; Huber RJ
    Front Genet; 2022; 13():1045738. PubMed ID: 36437924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mfsd8 Modulates Growth and the Early Stages of Multicellular Development in
    Yap SQ; Kim WD; Huber RJ
    Front Cell Dev Biol; 2022; 10():930235. PubMed ID: 35756993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computed tomography provides enhanced techniques for longitudinal monitoring of progressive intracranial volume loss associated with regional neurodegeneration in ovine neuronal ceroid lipofuscinoses.
    Russell KN; Mitchell NL; Anderson NG; Bunt CR; Wellby MP; Melzer TR; Barrell GK; Palmer DN
    Brain Behav; 2018 Sep; 8(9):e01096. PubMed ID: 30136763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An altered secretome is an early marker of the pathogenesis of CLN6 Batten disease.
    Best HL; Clare AJ; McDonald KO; Wicky HE; Hughes SM
    J Neurochem; 2021 May; 157(3):764-780. PubMed ID: 33368303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of the Batten disease gene CLN3 prevents exit from the TGN of the mannose 6-phosphate receptor.
    Metcalf DJ; Calvi AA; Seaman MNj; Mitchison HM; Cutler DF
    Traffic; 2008 Nov; 9(11):1905-14. PubMed ID: 18817525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretion and function of Cln5 during the early stages of Dictyostelium development.
    Huber RJ; Mathavarajah S
    Biochim Biophys Acta Mol Cell Res; 2018 Jul; 1865(10):1437-1450. PubMed ID: 30048658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel MFSD8 mutation in a Russian patient with neuronal ceroid lipofuscinosis type 7: a case report.
    Kozina AA; Okuneva EG; Baryshnikova NV; Krasnenko AY; Tsukanov KY; Klimchuk OI; Kondakova OB; Larionova AN; Batysheva TT; Surkova EI; Shatalov PA; Ilinsky VV
    BMC Med Genet; 2018 Aug; 19(1):151. PubMed ID: 30144815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cathepsin D-deficient Drosophila recapitulate the key features of neuronal ceroid lipofuscinoses.
    Myllykangas L; Tyynelä J; Page-McCaw A; Rubin GM; Haltia MJ; Feany MB
    Neurobiol Dis; 2005; 19(1-2):194-9. PubMed ID: 15837574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.